Filing Details

Accession Number:
0001333493-20-000005
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-24 16:22:18
Reporting Period:
2020-01-22
Accepted Time:
2020-01-24 16:22:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333493 Ehealth Inc. EHTH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1327337 N Scott Flanders C/O Ehealth, Inc.
2625 Augustine Drive, Second Floor
Santa Clara CA 95054
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-01-22 31,722 $100.28 766,637 No 4 S Direct
Common Stock Disposition 2020-01-24 24,478 $111.54 742,159 No 4 S Direct
Common Stock Disposition 2020-01-24 8,739 $112.47 733,420 No 4 S Direct
Common Stock Disposition 2020-01-24 19,859 $113.29 713,561 No 4 S Direct
Common Stock Disposition 2020-01-24 14,393 $114.22 699,168 No 4 S Direct
Common Stock Disposition 2020-01-24 21,009 $115.28 678,159 No 4 S Direct
Common Stock Disposition 2020-01-24 800 $116.07 677,359 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,000 Indirect UTMA Accounts For Grandchildren
Footnotes
  1. The transactions reported on this date were effected pursuant to a Rule 10b5-1 trading plan. The shares were originally purchased by Mr. Flanders in the open market in August 2016 and August 2010, respectively.
  2. The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.86. The reporting persons undertakes to provide to eHealth, Inc., any security holder of eHealth, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in this footnote and in footnotes (4) through (9) of this Form 4
  3. Total amount of shares beneficially owned includes shares deferred upon vesting of certain restricted stock units. The deferred shares will be settled in accordance with the terms of the deferral election.
  4. The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.92 to $111.9199.
  5. The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.92 to $112.9199.
  6. The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.92 to $113.9199.
  7. The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.92 to $114.9199.
  8. The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.92 to $115.9199.
  9. The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.92 to $116.065.